The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation ; volume:20 ; number:1 ; day:1 ; month:6 ; year:2020 ; pages:1-11 ; date:12.2020
BMC cancer ; 20, Heft 1 (1.6.2020), 1-11, 12.2020
- Urheber
-
Humphries, Matthew P.
Craig, Stephanie G.
Kacprzyk, Rafal
Fisher, Natalie C.
Bingham, Victoria
McQuaid, Stephen
Murray, Graeme I.
McManus, Damian
Turkington, Richard C.
James, Jacqueline
Salto-Tellez, Manuel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-020-06987-y
- URN
-
urn:nbn:de:101:1-2020080401003373153058
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Humphries, Matthew P.
- Craig, Stephanie G.
- Kacprzyk, Rafal
- Fisher, Natalie C.
- Bingham, Victoria
- McQuaid, Stephen
- Murray, Graeme I.
- McManus, Damian
- Turkington, Richard C.
- James, Jacqueline
- Salto-Tellez, Manuel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy
![Pediatric molecular pathology, [...]. Quantitation and applications](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Pediatric molecular pathology, [...]. Quantitation and applications
Immune checkpoint analysis in lip cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy
Pediatric molecular pathology, [...]. Quantitation and applications
Immune checkpoint analysis in lip cancer
Cancer immunotherapy beyond immune checkpoint inhibitors
Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Neurosarcoidosis following Immune Checkpoint Inhibition
Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy
Pediatric molecular pathology, [...]. Quantitation and applications
Immune checkpoint analysis in lip cancer